Profilo
Peter L.
Nara was the founder of Lantern Pharma, Inc. (founded in 2013) where he held the title of Director & Chief Business Officer.
He was also the founder of Biological Mimetics, Inc. (founded in 1996) where he held the title of Chairman, President & Chief Executive Officer.
Currently, Dr. Nara is the CSO, Director & VP-Business Development at Keystone Bio, Inc.
Posizioni attive di Peter L. Nara
Società | Posizione | Inizio |
---|---|---|
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Fondatore | 01/01/1996 |
Keystone Bio, Inc.
Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Peter L. Nara
Società | Posizione | Fine |
---|---|---|
LANTERN PHARMA INC. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LANTERN PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Health Technology |
Keystone Bio, Inc.
Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Health Technology |
- Borsa valori
- Insiders
- Peter L. Nara